ROMELLA WATLER: Open Payments
NPI 1619454154 · GOLD CANYON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$471 in 23 payments from 11 companies in 2025. Trend: 2023 $211 · 2024 $331 · 2025 $471
Food & beverage: $471
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $68 |
| Lilly USA, LLC | 3 | $59 |
| Phathom Pharmaceuticals, Inc. | 2 | $58 |
| Novo Nordisk Inc | 3 | $56 |
| Astellas Pharma US Inc | 2 | $49 |
| Exact Sciences Corporation | 2 | $44 |
| Amgen Inc. | 2 | $36 |
| GlaxoSmithKline, LLC. | 2 | $33 |
| ABBVIE INC. | 1 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
Products named: MOUNJARO, VOQUEZNA, Veozah, Cologuard Collection Kit, AIRSUPRA, EVENITY, TRELEGY ELLIPTA, QULIPTA.
Industry payments across AZ — which companies pay providers there.
